Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Avocado and mango diet shows promise for Pre-Diabetes health

NCT ID NCT05353790

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether eating one avocado and one cup of mango daily for 8 weeks could improve blood vessel health and thinking in 82 adults with pre-diabetes. Participants were randomly assigned to either a diet including these fruits or a matched control diet. Researchers measured artery flexibility, blood pressure, eye blood vessels, and cognitive function. The goal was to see if this simple dietary change could help manage pre-diabetes and reduce related health risks.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
avocado and mango
What this could lead to
If it works, this could point toward a simple dietary approach to improve blood vessel function and possibly slow progression from pre-diabetes to type 2 diabetes.
What could go wrong
This is a small, completed trial with 82 participants, so results may not apply to everyone. Dietary changes alone may not be enough to reverse pre-diabetes, and any benefits might be modest.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

82 people

The number who actually took part.

Started

Oct 2021

Finished

Dec 2025

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

25 to 70 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Men or women, age 25-70 year- Fasting blood glucose concentration between 100 mg/dL and 125 mg/dL at screening visit * Blood pressure 120-160 mmHg systolic or 80-100 mm/Hg diastolic at screening visit * Nonsmokers (past smokers can be allowed if they have abstinence for minimum of 12 months) * Judged to be in good health on the basis of the medical history (i.e., no clinical evidence of cardiovascular, metabolic, respiratory, renal, gastrointestinal or hepatic disease * Not taking any medications that would interfere with outcomes of the study, (e.g., lipid lowering medications, anti-inflammatory drugs, dietary supplements, etc.) * Able to provide informed consent * Able to comply and perform the procedures requested by the protocol (follow the dietary plans, come to scheduled visits, record food intake in a diary, complete questionnaires, provide blood samples and complete other tests (eye and brain/cognitive function) * Able to maintain usual physical activity pattern * Able to abstain from alcohol consumption and avoid vigorous physical activity for 24 hours prior to and during study visit Exclusion Criteria: * Men and women who have blood pressure \>160 mmHg (systolic)/100 mmHg (diastolic) at screening visit * Men and women who have fasting blood glucose concentration \<100 or \>125 mg/dL at screening visit * Abnormal Thyroid-stimulating Hormone (TSH) at screening visit * Men and women with diabetes * History of cardiovascular event, respiratory, renal, gastrointestinal, hepatic or eye disease or surgery (e.g., heart failure, myocardial infarction, stroke, angina, related surgeries, etc.) that, in the opinion of the investigator, could interfere with the interpretation of the study results. * High refractive error (+/- 6.00 D, axial length greater than 26 mm or less than 22mm), astigmatism \>3.00D, impaired vision/not correctible to 20/20, high eye pressures (\>21 mmHg) and narrow angles (\< grade 3 Van Herick) in the study eye as confirmed by screening eye exam at IEI screening visit * Head injury in past 6 months * Men and women with cancer other than non-melanoma skin cancer in previous 5 years * Taking medication or dietary supplements that may interfere with the outcomes of the study, (e.g., antioxidant supplement, anti-inflammation, lipid-lowering medication, blood pressure-lowering medication, etc.). Subjects may choose to go off dietary supplements (requires 30-day washout; e.g., fish oil, etc.) * Vegan or other extreme dietary regimens (e.g., Atkins diet, etc.) as judged by the investigator * Known or suspected intolerance, allergies or hypersensitivity to study foods or treatments * Current smoker or smoked/vaped within the last 12 months * Unstable weight: Actively losing or gaining weight or trying to lose or gain weight. Gained or lost weight +/- 5 kg (11 lbs.) in previous 2 months. * Substance (alcohol or drug) abuse within the last 2 years * Present with significant psychiatric or neurological disturbances * Women who are known to be pregnant or who are intending to become pregnant over the course of the study * Women who are lactating * Major trauma or a surgical event within 2 months or longer depending on trauma or event and after consultation with PI. * Has used antibiotics within the previous 2 months * History of an eating disorder (e.g., anorexia nervosa, bulimia nervosa, or binge eating) diagnosed by a health professional * Excessive coffee and tea consumers (\> 4 cups/d) * Donated blood within last 3 months * Men and women who do excessive exercise regularly or are an athlete * Women who are taking unstable dose and brand of hormonal contraceptives and/or stable dose and brand less than 6 months * Unusual working hours (e.g., working overnight; 3rd shift)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cognitive change are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Clinical Nutrition Research Center

    Chicago, Illinois, 60616, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.